Equitar
Category
Equitar Brand names, Equitar Analogs
Equitar Brand Names Mixture
Equitar Chemical_Formula
C20H23NS
Equitar RX_link
No information avaliable
Equitar fda sheet
Equitar msds (material safety sheet)
Equitar Synthesis Reference
No information avaliable
Equitar Molecular Weight
309.469 g/mol
Equitar Melting Point
< 25 oC
Equitar H2O Solubility
Soluble as HCl salt
Equitar State
Liquid
Equitar LogP
5.7
Equitar Dosage Forms
Tablets (oral, 1 mg)
Equitar Indication
Used for the symptomatic treatment of parkinsonism.
Equitar Pharmacology
Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.
Equitar Absorption
Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.
Equitar side effects and Toxicity
Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.
Equitar Patient Information
Equitar Organisms Affected
Humans and other mammals
